Director of Technical Accounting & SEC Reporting - Biotech

Job Details

HYBRID, 300k+ total compensation, Base/Bonus/Equity

This Jobot Job is hosted by:
Dylan Currier

Salary: $200,000 - $260,000 per year

Are you a fit? Easy Apply now by clicking the "Easy Apply" button and sending us your resume.

Want to learn more about this role and Jobot? Click our Jobot logo and follow our Linked In page!

We are a clinical-stage biotechnology company preparing to establish and scale our U.S. finance infrastructure. As our first U.S.

-based finance hire, this role presents a unique opportunity to build the technical accounting and SEC reporting foundation that will support the company’s transition to a fully public-company-ready environment over the next 12–24 months.

This is a highly visible, hands‑on role for an entrepreneurial accounting leader who thrives in a build environment and wants to play a foundational role in shaping the U.S. finance function.

• Base Salary: $225,000 – $275,000
• Annual Bonus: 15%
• Participation in global stock option program
• 401(k) plan
• Health insurance
• Life insurance

• Lead preparation and review of SEC filings, including Forms 10-K, 10-Q, and proxy statements
• Establish SEC reporting timelines, processes, and documentation
• Ensure full compliance with U.S. GAAP and SEC regulations
• Partner with the publicly traded Danish parent company to align U.S. reporting requirements
• Develop and maintain accounting policies and technical memos
• Serve as the primary liaison with external auditors on U.S. GAAP and SEC matters
• Build the foundation for a scalable public-company reporting function

• Deep knowledge of U.S. GAAP
• Strong SEC reporting experience (10-K, 10-Q, proxy statements)
• Public‑company reporting experience (biotech preferred)

• Hands‑on clinical trial accrual accounting
• Partnering directly with CROs to review contracts, milestones, and trial spend
• Managing accrual calculations and documentation
• Supporting expansion of clinical trial accounting into Auxilius
• Ensuring proper financial reporting as additional trials are onboarded
• Experience in clinical‑stage biotech or listed biotech companies is strongly preferred.

• Support implementation of a stock option administration system
• Assist with administration and accounting for global equity programs
• Provide oversight and internal control review of U.S. payroll (execution may be outsourced)
• Support system enhancements within Microsoft 365 environment
• Participate in finance infrastructure build‑out as the U.S. organization scales

• Partner with Senior Finance Manager to design and implement internal controls
• Build SOX‑compliant processes and documentation
• Establish control frameworks across accounting, payroll, equity, and financial reporting
• Ensure sustainable governance as the company scales

A strong internal controls mindset is absolutely essential.

• CPA strongly preferred
• 8–12+ years of progressive accounting experience
• Significant SEC reporting experience (10-K, 10-Q, proxy)
• Deep U.S. GAAP expertise
• Experience in biotech, clinical‑stage, or publicly listed life sciences company preferred
• Strong internal controls and SOX readiness experience
• Experience working with global parent organizations a plus
• Familiarity with clinical trial accounting systems (e.g., Auxilius) preferred
• Experience overseeing U.S. payroll from an internal controls perspective
• Experience with stock‑based compensation programs preferred

• Entrepreneurial and comfortable building from scratch
• Hands‑on and execution‑oriented – willing to “roll up sleeves”
• Thrives in ambiguity and growth environments
• Highly detail‑oriented with strong technical depth
• Strong cross‑functional communicator
• Comfortable operating without direct reports
• Motivated by long‑term infrastructure building rather than team management (for now)

Interested in hearing more? Easy Apply now by clicking the "Easy Apply" button.

Want to learn more about this role and Jobot? Click our Jobot logo and follow our Linked In page!